Sec Form 13D Filing - Luiz Busnello filing for Nvni Group Limited Ordinary Shares (NVNI) - 2025-04-03

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D



Comment for Type of Reporting Person:
(1) Represents 900,192 shares of Nvni Group Limited's (the "Issuer") ordinary shares, par value $0.00001 per share ("Ordinary Shares") underlying options granted to Luis Busnello (the "Reporting Person") under the Nuvini S.A. Stock Option Plan.(2) Represents 1,010,326 Ordinary Shares for which Labsyl Ltd. ("Labsyl") is the record holder. The Reporting Person is the controlling member of Labsyl with the power to vote and dispose of such Ordinary Shares, subject to the irrevocable power of attorney and proxy relating to the 1,010,326 Ordinary Shares owned by Labsyl, dated September 28, 2023 (the "Labsyl Power of Attorney") in favor of Pierre Schurmann, the Chief Executive Officer and Chairman of the board of directors (the "Board") of the Issuer. Pursuant to the Labsyl Power of Attorney, Labsyl irrevocably designated, constituted and appointed Mr. Schurmann as its proxy and duly authorized attorney-in-fact to vote such Ordinary Shares.(3) The percentage set forth in row (13) is based on the Issuer's 92,257,843 Ordinary Shares outstanding on March 31, 2025, as disclosed in the Issuer's Shell Company Report on Form 20-F filed with the Securities and Exchange Commission ("SEC") on December 26, 2024.


SCHEDULE 13D

 
Luiz Busnello
 
Signature:/s/ Luiz Busnello
Name/Title:Luiz Busnello
Date:04/03/2025
primary_doc.xml